Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swasth Kare is an innovative healthcare and medical technology company based in Chandigarh, India, and born out of the Landsmiths Group's research and development wing. Established in 2019, the company focuses on advanced medical solutions, including graphene-based drug delivery, singlet oxygen cell regeneration, and bleed management. Swasth Kare is the exclusive pan-India distributor of SeraSeal, a revolutionary primary hemostatic agent developed by Wortham Laboratories that stops arterial and venous bleeding within seconds. The company is actively expanding its operations across South Asia and Africa, aiming to minimize blood loss and reduce the need for blood transfusions in trauma and surgical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swast Kare.